Funder: NIH: Office of Behavioral and Social Sciences Research (OBSSR), NIH: National Institute of Aging (NIA), NIH: National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH: National Institute of Environmental Health Sciences (NIEHS), NIH: National Center for Complementary and Integrative Health (NCCIH), NIH: National Cancer Institute (NCI), NIH: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH: National Institute of Nursing Research (NINR), NIH: National Human Genome Research Institute (NHGRI), NIH: National Heart, Lung, and Blood Institute (NHLBI)

These submissions are encouraged to consider four broad areas;

1. Adherence to or transmission reductions from various public health containment and mitigation efforts including but not limited to risk communication, handwashing, disinfecting surfaces, social distancing, self-quarantine, paid sick leave, school closures, and business closures.
2. Economic, social, and personal well-being impacts of these various containment and mitigation actions (e.g., unemployment, social isolation, stress, mental health, substance use, physical activity)
3. The impacts and behavioral responses to misinformation being communicated about COVID-19 and its prevention, treatment and health effects via a range of information channels, including traditional and social media
4. Downstream health effects from these economic, social, and personal impacts including but not limited to substance use/abuse, mental illness, suicide, stress-related physical disorders, and limitations on healthcare access.

Applications in response to this NOSI must be submitted using the following targeted funding opportunities or subsequent re-issued equivalents:

• PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
• PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.
• The funding instrument, or activity code, will be the same as the parent award.

Topics: Co-Morbidities, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Transmission, Health Disparities, Healthcare Implementation, Mental Health, Prevention, Social Distancing